New Product: Recarbrio (imipenem monohydrate, cilastatin sodium, relebactam monohydrate) 500 mg/500 mg/250 mg powder for solution for infusion

This combination of beta-lactamase inhibitor, carbapenem and enzyme inhibitor which blocks renal metabolism of imipenem (cilastatin) is indicated for treatment of aerobic Gram-negative infections with limited treatment options including hospital-acquired bacterial pneumonia.


electronic Medicines compendium